Search Results - Gohil, Satyen Harish

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies

    cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies by Pedersen, Christina Bligaard, Dam, Søren Helweg, Barnkob, Mike Bogetofte, Leipold, Michael D., Purroy, Noelia, Rassenti, Laura Z., Kipps, Thomas J., Nguyen, Jennifer, Lederer, James Arthur, Gohil, Satyen Harish, Wu, Catherine J., Olsen, Lars Rønn

    Published in Nature communications
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC

    Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC by Harrasser, Micaela, Gohil, Satyen Harish, Lau, Hiu, Della Peruta, Marco, Muczynski, Vincent, Patel, Dominic, Miranda, Elena, Grigoriadis, Kristiana, Grigoriadis, Anita, Granger, David, Evans, Rachel, Nathwani, Amit Chunilal

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors

    An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors by Gohil, Satyen Harish, Paredes-Moscosso, Solange Rosa, Harrasser, Micaela, Vezzalini, Marzia, Scarpa, Aldo, Morris, Emma, Davidoff, Andrew M., Sorio, Claudio, Nathwani, Amit Chunilal, Della Peruta, Marco

    Published in Oncoimmunology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A Novel Humanised ROR1 Bi-Specific T-Cell Engager Molecule for the Treatment of Chronic Lymphocytic Leukaemia

    A Novel Humanised ROR1 Bi-Specific T-Cell Engager Molecule for the Treatment of Chronic Lymphocytic Leukaemia by Gohil, Satyen Harish, Harrasser, Micaela, Paredes-Moscosso, Solange R, Nathwani, Amit C, Della Peruta, Marco

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

    Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells by Paredes-Moscosso, Solange R, Della Peruta, Marco, Gohil, Satyen Harish, Harrasser, Micaela, Nathwani, Amit C

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

    The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia by Sun, Clare, Chen, Yun-Ching, Martinez Zurita, Aina, Baptista, Maria Joao, Pittaluga, Stefania, Liu, Delong, Rosebrock, Daniel, Gohil, Satyen Harish, Saba, Nakhle S., Davies-Hill, Theresa, Herman, Sarah E. M., Getz, Gad, Pirooznia, Mehdi, Wu, Catherine J., Wiestner, Adrian

    Published in Blood advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies

    Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies by Gohil, Satyen Harish, Della Peruta, Marco, Paredes-Moscosso, Solange R, Harrasser, Micaela, Cheung, Gordon Weng-Kit, Davies, David M, Pule, Martin A, Nathwani, Amit C

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia

    LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia by Gohil, Satyen Harish, Maciocia, Nicola, Patrick, Pip, Roberts, Thomas, Counsell, Nicholas, Smith, Paul, Clifton-Hadley, Laura, Cwynarski, Kate, Pettitt, Andrew, Nathwani, Amit Chunilal

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: